Balancing benefits, costs, and harms: policy implications of expanding cancer susceptibility testing from genetics clinics to the general population. // The Lancet Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S1470204526003906?dgcid=rss_sd_all
Balancing benefits, costs, and harms: policy implications of expanding cancer susceptibility testing from genetics clinics to the general population. The Lancet Oncology. https://www.sciencedirect.com/science/article/pii/S1470204526003906?dgcid=rss_sd_all
“Balancing benefits, costs, and harms: policy implications of expanding cancer susceptibility testing from genetics clinics to the general population.” The Lancet Oncology.
@article{article99119,
title = {Balancing benefits, costs, and harms: policy implications of expanding cancer susceptibility testing from genetics clinics to the general population},
journal = {The Lancet Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S1470204526003906?dgcid=rss_sd_all}
}